2 results
Approved WMOCompleted
To provide continued bevacizumab therapy as single agent or in combination with an anti-cancer drug to patients with cancer, who were previously enrolled in a F. Hoffmann-La Roche (Roche)/ Genentech sponsored bevacizumab study (i.e. the Parent, P-…
Approved WMOCompleted
To assess whether patients receiving simple hallux valgus surgery ambulate independently earlier after spinal anesthesia combined with LIA, compared to popliteal blocks. We hypothesize that both groups will demonstrate sufficient pain relief.